NCT03009708View on ClinicalTrials.gov

Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

September 12, 2017

Study Completion Date

November 6, 2017

Conditions
Allograft
Interventions
OTHER

Blood samples

Two blood tubes will be collected each week during 8 weeks maximum for the present study. Samples will start at day 30 post-graft and finish at day 90 post-graft maximum.

Trial Locations (1)

42 270

Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez

All Listed Sponsors
collaborator

Groupe sur l'Immunité des Muqueuses et Agents Pathogènes, (GIMAP)

UNKNOWN

collaborator

Association Stéphanoise Pour la Recherche en Hématologie-Oncologie (ASPHRO)

UNKNOWN

lead

Institut de Cancérologie de la Loire

OTHER

NCT03009708 - Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen | Biotech Hunter | Biotech Hunter